SLCB050
SLCB050 is a compound that blocks the interaction between DX2 and p14/ARF and has anticancer activity. SLCB050 reduces the viability of human lung cancer cells, especially small cell lung cancer cells, in a p14/ARF-dependent manner and induces apoptosis and senescence[1].
Product Specifications
CAS Number
1848971-16-3
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/slcb050.html
Smiles
CC1(OC2=CC(OC(C=C3)=O)=C3C=C2C[C@@H]1OC(/C=C/C4=CC=CO4)=O)C
Molecular Formula
C21H18O6
Molecular Weight
366.36
References & Citations
[1]Ah-Young, et al. "Inhibiting DX2-p14/ARF interaction exerts antitumor effects in lung cancer and delays tumor progression." Cancer Research 76.16 (2016) : 4791-4804.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1976-100 1x 100 µL
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (rLPFS2/1611), 0.2mg/mL
Sign In for Pricing
View Details 
GA113103 1 Kit
Human TSC22 domain family, member 4 (TSC22D4) activation kit by CRISPRa
Sign In for Pricing
View Details 
RC-15155-01 50 μL
Recombinant Estrogen Inducible Protein pS2 Antibody
Sign In for Pricing
View Details